Provided by Tiger Trade Technology Pte. Ltd.

Annovis Bio, Inc.

1.75
-0.0700-3.85%
Pre-market: 1.800.0500+2.86%04:00 EDT
Volume:670.72K
Turnover:1.18M
Market Cap:74.45M
PE:-0.98
High:1.83
Open:1.83
Low:1.74
Close:1.82
52wk High:5.50
52wk Low:1.54
Shares:42.54M
Float Shares:35.32M
Volume Ratio:1.11
T/O Rate:1.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7895
EPS(LYR):-1.4040
ROE:-703.68%
ROA:-142.36%
PB:-17.50
PE(LYR):-1.25

Loading ...

Annovis Bio CEO presents multi-protein Alzheimer’s model at Fierce Biotech Week 2026

Reuters
·
May 07

Annovis Bio announces annual shareholder meeting

Reuters
·
May 01

Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio

GlobeNewswire
·
Apr 28

Annovis Bio Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Apr 14

Annovis Bio raises USD 10 million in underwritten public offering

Reuters
·
Apr 10

Annovis Bio Prices Registered Direct Offering to Fund Trials

TIPRANKS
·
Apr 10

BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman

Reuters
·
Apr 10

BRIEF-Annovis Announces $10 Million Underwritten Offering Of Common Stock And Accompanying Warrants

Reuters
·
Apr 09

Annovis Bio prices USD 10 million stock offering with warrants at USD 1.9 unit

Reuters
·
Apr 09

Annovis Bio Inc - Combined Offering Price per Share and Warrant Is $1.90

THOMSON REUTERS
·
Apr 09

Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants

GlobeNewswire
·
Apr 09

Top Insider Makes Bold Multi-Million Dollar Move Into Annovis Bio

TIPRANKS
·
Apr 04

Annovis Bio director Michael B. Hoffman buys $1.5 million common shares

Reuters
·
Apr 04

Annovis Bio wins U.S. patent for buntanetap to treat brain infection-related injuries

Reuters
·
Apr 02

Annovis Publishes Historical Review of Buntanetap in The Scientist

GlobeNewswire
·
Mar 31

Annovis Bio Inc - CEO Maria Maccecchini to Serve as Acting CFO Until Replacement Is Identified - SEC Filing

THOMSON REUTERS
·
Mar 26

Annovis Bio Inc - Mark Guerin Steps Down as CFO Effective March 23, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 26

Annovis Bio CFO Mark Guerin departs; CEO Maria Maccecchini becomes acting CFO effective March 23, 2026

Reuters
·
Mar 26

Annovis Bio enters partnership with NeuroRPM

TIPRANKS
·
Mar 19

Annovis Bio partners with NeuroRPM for AI wearable monitoring in Parkinson’s trial

Reuters
·
Mar 19